These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10392810)

  • 1. Altered fractionation: limited by mucosal reactions?
    Kaanders JH; van der Kogel AJ; Ang KK
    Radiother Oncol; 1999 Mar; 50(3):247-60. PubMed ID: 10392810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.
    Awwad HK; Lotayef M; Shouman T; Begg AC; Wilson G; Bentzen SM; Abd El-Moneim H; Eissa S
    Br J Cancer; 2002 Feb; 86(4):517-23. PubMed ID: 11870530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered fractionation in the management of head and neck cancer.
    Ang KK
    Int J Radiat Biol; 1998 Apr; 73(4):395-9. PubMed ID: 9587077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?
    Denham JW; Peters LJ; Johansen J; Poulsen M; Lamb DS; Hindley A; O'Brien PC; Spry NA; Penniment M; Krawitz H; Williamson S; Bear J; Tripcony L
    Radiother Oncol; 1999 Aug; 52(2):157-64. PubMed ID: 10577701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
    Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered fractionation trials in head and neck cancer.
    Ang KK
    Semin Radiat Oncol; 1998 Oct; 8(4):230-6. PubMed ID: 9873100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
    Bentzen SM; Saunders MI; Dische S
    Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.
    Maciejewski B; Skladowski K; Pilecki B; Taylor JM; Withers RH; Miszczyk L; Zajusz A; Suwinski R
    Radiother Oncol; 1996 Aug; 40(2):137-45. PubMed ID: 8884967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules.
    Fowler JF; Harari PM; Leborgne F; Leborgne JH
    Radiother Oncol; 2003 Nov; 69(2):161-8. PubMed ID: 14643953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity antagonists in head and neck cancer.
    Trotti A
    Semin Radiat Oncol; 1998 Oct; 8(4):282-91. PubMed ID: 9873106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck.
    Mendenhall WM; Parsons JT
    Cancer Invest; 1998; 16(8):594-603. PubMed ID: 9844620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Reactions as Dose-Limiting Factors in Radiotherapy.
    Kaanders JH; Ang KK
    Semin Radiat Oncol; 1994 Apr; 4(2):55-67. PubMed ID: 10717092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to accelerated fractionation in the head and neck region.
    Zackrisson B; Franzén L; Henriksson R; Littbrand B
    Acta Oncol; 1994; 33(4):391-6. PubMed ID: 8018371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial.
    Leborgne JH; Leborgne F; Zubizarreta E; Ortega B; Mezzera J
    Radiother Oncol; 1998 May; 47(2):145-8. PubMed ID: 9683361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Three Fractionation Schedules in Radiotherapy for Early Glottic Squamous Cell Carcinoma.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Shimizu D; Kimoto T; Nishimura T; Kawabata K; Nagasawa S; Machida K; Yoshino Y; Watanabe S; Sugiyama Y; Arai A; Hirano S; Yamada K
    In Vivo; 2020; 34(5):2769-2774. PubMed ID: 32871813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
    Dubben HH; Beck-Bornholdt HP
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
    [No Abstract]   [Full Text] [Related]  

  • 17. [The hyperfractionated radiotherapy of tumors in the head-neck area].
    Dubben HH; Baumann M; Fassbender T; Beck-Bornholdt HP
    Strahlenther Onkol; 1992 Jul; 168(7):373-82. PubMed ID: 1496447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.
    Dobrowsky W; Naudé J
    Radiother Oncol; 2000 Nov; 57(2):119-24. PubMed ID: 11054514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
    Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.